Skip to Content

508 Results Found

  • Article
  • Open Access
2 Citations
2,561 Views
9 Pages

Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form—Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire

  • Mihnea-Alexandru Găman,
  • Robyn Marie Scherber,
  • Iulia Ursuleac,
  • Ana Manuela Crişan and ,
  • Sorina Nicoleta Bădeliţă,
  • Bogdan Octavian Ionescu,
  • Alexandra Elena Ghiaur,
  • Melen Brînză,
  • Nicoleta Pîrciulescu and
  • Daniel Coriu
  • + 8 authors+ 3 authors

2 June 2024

Background: Patients with myeloproliferative neoplasms (MPNs) experience a high disease-related symptom burden. A specific instrument to evaluate quality of life (QoL), i.e., the MPN Symptom Assessment Form Total Symptom Score (MPN-SAF TSS; MPN-10),...

(This article belongs to the Special Issue Myeloproliferative Neoplasms (MPN): Recent Advances, Current Practices and Future Perspectives)
  • Review
  • Open Access
35 Citations
6,982 Views
21 Pages

Thromboinflammation in Myeloproliferative Neoplasms (MPN)—A Puzzle Still to Be Solved

  • Vikas Bhuria,
  • Conny K. Baldauf,
  • Burkhart Schraven and
  • Thomas Fischer

Myeloproliferative neoplasms (MPNs), a group of malignant hematological disorders, occur as a consequence of somatic mutations in the hematopoietic stem cell compartment and show excessive accumulation of mature myeloid cells in the blood. A major ca...

(This article belongs to the Collection Feature Papers in “Molecular Biology”)
  • Review
  • Open Access
83 Citations
7,047 Views
40 Pages

Recent Advances of Fe(III)/Fe(II)-MPNs in Biomedical Applications

  • Weipeng Chen,
  • Miao Liu,
  • Hanping Yang,
  • Alireza Nezamzadeh-Ejhieh and ,
  • Chengyu Lu,
  • Ying Pan,
  • Jianqiang Liu and
  • Zhi Bai
  • + 3 authors+ 0 author

Metal–phenolic networks (MPNs) are a new type of nanomaterial self-assembled by metal ions and polyphenols that have been developed rapidly in recent decades. They have been widely investigated, in the biomedical field, for their environmental friend...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Review
  • Open Access
2 Citations
4,181 Views
12 Pages

Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical Features

  • Valentina Giai,
  • Carolina Secreto,
  • Roberto Freilone and
  • Patrizia Pregno

30 September 2021

Philadelphia negative Myeloproliferative Neoplasms (MPN) are a heterogeneous group of hematopoietic stem cell diseases. MPNs show different risk grades of thrombotic complications and acute myeloid leukemia evolution. In the last couple of decades, f...

(This article belongs to the Special Issue Myeloproliferative Diseases: From Diagnosis to Treatment Approach, through the Molecular Landscape)
  • Review
  • Open Access
1 Citations
2,726 Views
18 Pages

27 February 2025

Patients with chronic, indolent myeloproliferative neoplasms (MPNs) are at risk for transformation to highly lethal leukemia, although targetable mechanisms driving progression remain elusive. We discovered that the High Mobility Group A1 (HMGA1) gen...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Review
  • Open Access
10 Citations
9,242 Views
27 Pages

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs)

  • Xinyu Ma,
  • Zhibo Zhou,
  • Shuyu Gu,
  • Yan Guo and ,
  • Tianqing Zhou,
  • Ruonan Shao,
  • Jinsong Yan,
  • Wei Chen and
  • Xiaofeng Shi
  • + 4 authors+ 0 author

27 September 2025

Myeloproliferative neoplasms (MPNs) encompass three principal subtypes: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). These hematologic malignancies originate from clonal hematopoietic stem cells (HSCs) and...

(This article belongs to the Special Issue Novel Advances in the Molecular Understanding of Myeloproliferative Neoplasms (MPNs))
  • Review
  • Open Access
53 Citations
9,476 Views
32 Pages

14 August 2020

Myeloproliferative neoplasms (MPNs) constitute a group of disorders identified by an overproduction of cells derived from myeloid lineage. The majority of MPNs have an identifiable driver mutation responsible for cytokine-independent proliferative si...

(This article belongs to the Special Issue Pathophysiology and Molecular Targets in Myeloid Neoplasia)
  • Review
  • Open Access
73 Citations
13,640 Views
18 Pages

Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives

  • Julian Baumeister,
  • Nicolas Chatain,
  • Alexandros Marios Sofias,
  • Twan Lammers and
  • Steffen Koschmieder

16 December 2021

Classical BCR-ABL-negative myeloproliferative neoplasms (MPN) are a heterogeneous group of hematologic malignancies, including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), as well as post-PV-MF and post-ET-...

(This article belongs to the Collection Epigenetics in Myeloproliferative Neoplasms and Acute Myeloid Leukemia)
  • Article
  • Open Access
20 Citations
8,502 Views
26 Pages

P40 and P90 from Mpn142 are Targets of Multiple Processing Events on the Surface of Mycoplasma pneumoniae

  • Michael Widjaja,
  • Iain J. Berry,
  • Elsa J. Pont,
  • Matthew P. Padula and
  • Steven P. Djordjevic

16 December 2015

Mycoplasma pneumoniae is a significant cause of community acquired pneumonia globally. Despite having a genome less than 1 Mb in size, M. pneumoniae presents a structurally sophisticated attachment organelle that (i) provides cell polarity, (ii) dire...

(This article belongs to the Special Issue Microbial Proteomics)
  • Article
  • Open Access
25 Citations
5,592 Views
21 Pages

Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry

  • Judith Gecht,
  • Ioannis Tsoukakis,
  • Kim Kricheldorf,
  • Frank Stegelmann and ,
  • Martine Klausmann,
  • Martin Griesshammer,
  • Holger Schulz,
  • Wiebke Hollburg,
  • Joachim R. Göthert and
  • Steffen Koschmieder
  • + 21 authors+ 16 authors

13 August 2021

Inflammation-induced thrombosis represents a severe complication in patients with myeloproliferative neoplasms (MPN) and in those with kidney dysfunction. Overlapping disease-specific attributes suggest common mechanisms involved in MPN pathogenesis,...

(This article belongs to the Special Issue Advances in the Pathobiology, Diagnosis and Treatment of Chronic Myeloid Neoplasms)
  • Article
  • Open Access
928 Views
15 Pages

Beyond Ribosomal Mutations: Identification of MPN_080 as a Novel ATPase-Dependent Determinant of Macrolide Resistance in Mycoplasma pneumoniae

  • Shaoli Li,
  • Yuyan Xia,
  • Fei Zhao,
  • Xiuwei Wang and ,
  • Zhengli Li,
  • Liyong Liu,
  • Junting Liu and
  • Mei Diao
  • + 3 authors+ 0 author

Mycoplasma pneumoniae is a significant pathogen responsible for community-acquired respiratory infections in children and adolescents, with the rising prevalence of macrolide-resistant M. pneumoniae (MRMP), particularly in Asia, presenting critical t...

(This article belongs to the Special Issue Advances in Mycoplasma Research, 2nd Edition)
  • Communication
  • Open Access
7 Citations
9,871 Views
8 Pages

An Optimized Most Probable Number (MPN) Method to Assess the Number of Thermophilic Free-Living Amoebae (FLA) in Water Samples

  • Mirna Moussa,
  • Isabel Marcelino,
  • Vincent Richard,
  • Jérôme Guerlotté and
  • Antoine Talarmin

Detection and quantification of pathogenic free-living amoebae (FLA) in water samples is critical for assessing water quality and for disease management issues. The most probable number (MPN) is commonly used to account for FLA in water. Nevertheless...

(This article belongs to the Special Issue Selected Papers from the International Meeting on the Biology and Pathogenicity of Free-Living Amoebae (FLAM2019))
  • Article
  • Open Access
12 Citations
5,464 Views
18 Pages

The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR–ABL- and JAK2V617F-Positive MPN

  • Stefan Tillmann,
  • Kathrin Olschok,
  • Sarah K. Schröder,
  • Marlena Bütow and ,
  • Julian Baumeister,
  • Milena Kalmer,
  • Vera Preußger,
  • Barbora Weinbergerova,
  • Kim Kricheldorf and
  • Nicolas Chatain
  • + 16 authors+ 11 authors

21 August 2021

Lipocalin 2 (LCN2), a proinflammatory mediator, is involved in the pathogenesis of myeloproliferative neoplasms (MPN). Here, we investigated the molecular mechanisms of LCN2 overexpression in MPN. LCN2 mRNA expression was 20-fold upregulated in perip...

(This article belongs to the Special Issue Pathogenesis and Natural History of Myeloproliferative Neoplasms)
  • Article
  • Open Access
4 Citations
3,700 Views
17 Pages

30 April 2025

Bacteriological water quality monitoring is of utmost importance for safeguarding public health against waterborne diseases. Traditional methods such as membrane filtration (MF), multiple tube fermentation (MTF), and enzyme-based assays are effective...

(This article belongs to the Section Biosensor and Bioelectronic Devices)
  • Article
  • Open Access
11 Citations
2,805 Views
24 Pages

MPN-RRT*: A New Method in 3D Urban Path Planning for UAV Integrating Deep Learning and Sampling Optimization

  • Yue Zheng,
  • Ang Li,
  • Zihan Chen,
  • Yapeng Wang and ,
  • Xu Yang and
  • Sio-Kei Im
  • + 1 author+ 0 author

2 July 2025

The increasing deployment of unmanned aerial vehicles (UAVs) in complex urban environments necessitates efficient and reliable path planning algorithms. While traditional sampling-based methods such as Rapidly exploring Random Tree Star (RRT*) are wi...

(This article belongs to the Special Issue Recent Advances in UAV Communications and Networks)
  • Review
  • Open Access
18 Citations
8,354 Views
24 Pages

27 July 2023

Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are hematological disorders characterized by both proliferative and dysplastic features. According to the 2022 International Consensus Classification (ICC), MDS/MPN consists of clonal monocytosis...

(This article belongs to the Special Issue Recent Advances in the Understanding of Myelodysplastic Syndrome and Acute Myeloid Leukemia)
  • Review
  • Open Access
14 Citations
6,633 Views
47 Pages

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

  • Hans Carl Hasselbalch,
  • Peter Junker,
  • Vibe Skov,
  • Lasse Kjær and ,
  • Trine A. Knudsen,
  • Morten Kranker Larsen,
  • Morten Orebo Holmström,
  • Mads Hald Andersen,
  • Christina Jensen and
  • Nicholas Willumsen
  • + 6 authors+ 1 author

29 August 2023

Philadelphia chromosome-negative chronic myeloproliferative neoplasms (MPNs) arise due to acquired somatic driver mutations in stem cells and develop over 10–30 years from the earliest cancer stages (essential thrombocythemia, polycythemia vera...

(This article belongs to the Topic Biomarker Development and Application)
  • Review
  • Open Access
30 Citations
10,350 Views
21 Pages

The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases

  • Marco Pizzi,
  • Giorgio Alberto Croci,
  • Marco Ruggeri,
  • Silvia Tabano and ,
  • Angelo Paolo Dei Tos,
  • Elena Sabattini and
  • Umberto Gianelli
  • + 2 authors+ 0 author

12 November 2021

Myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal hematopoietic stem cell disorders, characterized by increased proliferation of one or more myeloid lineages in the bone marrow. The classification and diagnostic criteria of MPNs...

(This article belongs to the Special Issue Pathogenesis and Natural History of Myeloproliferative Neoplasms)
  • Article
  • Open Access
8 Citations
3,649 Views
12 Pages

Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study

  • Fei Fei,
  • Amar Jariwala,
  • Sheeja Pullarkat,
  • Eric Loo and ,
  • Yan Liu,
  • Parastou Tizro,
  • Haris Ali,
  • Salman Otoukesh,
  • Idoroenyi Amanam and
  • Michelle Afkhami
  • + 10 authors+ 5 authors

23 September 2024

The accurate diagnosis and classification of myelodysplastic/myeloproliferative neoplasm (MDS/MPN) are challenging due to the overlapping pathological and molecular features of myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN). We...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Case Report
  • Open Access
3,386 Views
10 Pages

Clinical Discernment, Bone Marrow, and Molecular Diagnostics Are Equally Important to Solve the Phenotypic Mimicry among Subtypes of Myeloproliferative Neoplasms

  • Susann Schulze,
  • Nadia Jaekel,
  • Christin Le Hoa Naumann,
  • Anja Haak and ,
  • Marcus Bauer,
  • Claudia Wickenhauser and
  • Haifa Kathrin Al-Ali
  • + 2 authors+ 0 author

27 August 2021

The 2016 WHO classification integrates clinical, bone marrow (BM)-morphology, and molecular features to define disease entities. This together with the advancements in molecular detection and standardization of BM features enable an accurate diagnosi...

(This article belongs to the Special Issue Case Reports in Oncology)
  • Article
  • Open Access
15 Citations
6,819 Views
24 Pages

STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

  • Emir Hadzijusufovic,
  • Alexandra Keller,
  • Daniela Berger,
  • Georg Greiner and ,
  • Bettina Wingelhofer,
  • Nadine Witzeneder,
  • Daniel Ivanov,
  • Emmanuel Pecnard,
  • Harini Nivarthi and
  • Peter Valent
  • + 18 authors+ 13 authors

21 April 2020

Janus kinase 2 (JAK2) and signal transducer and activator of transcription-5 (STAT5) play a key role in the pathogenesis of myeloproliferative neoplasms (MPN). In most patients, JAK2 V617F or CALR mutations are found and lead to activation of various...

(This article belongs to the Special Issue Targeting STAT3 and STAT5 in Cancer)
  • Article
  • Open Access
7 Citations
3,705 Views
16 Pages

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia

  • Johanne Marie Holst,
  • Marie Beck Enemark,
  • Martin Bjerregaard Pedersen,
  • Kristina Lystlund Lauridsen and ,
  • Trine Engelbrecht Hybel,
  • Michael Roost Clausen,
  • Henrik Frederiksen,
  • Michael Boe Møller,
  • Peter Nørgaard and
  • Maja Ludvigsen
  • + 9 authors+ 4 authors

3 November 2021

Myeloproliferative neoplasia (MPN) and lymphoma are regarded as distinct diseases with different pathogeneses. However, patients that are diagnosed with both malignancies occur more frequently in the population than expected. This has led to the hypo...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
716 Views
9 Pages

Immature Platelet Fraction as a Potential Biomarker of Dysregulated Thrombopoiesis in Philadelphia-Negative Myeloproliferative Neoplasms

  • Ivan Zekanovic,
  • Tina Marketin,
  • Martina Moric Peric,
  • Drazen Zekanovic and ,
  • Ante Vulic,
  • Marija Milos,
  • Anamarija Bogic,
  • Marta Marcinkovic,
  • Petra Grbic Pavlovic and
  • Ana Boban
  • + 8 authors+ 3 authors

2 February 2026

Background/Objectives: Thrombotic events represent the leading cause of morbidity and mortality in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (Ph− MPNs), particularly in those aged > 60 years. The immature pl...

(This article belongs to the Special Issue Advancements in the Treatment of Myeloproliferative Neoplasms and Myelodysplastic Syndromes)
  • Review
  • Open Access
21 Citations
7,712 Views
22 Pages

Murine Models of Myelofibrosis

  • Sebastien Jacquelin,
  • Frederike Kramer,
  • Ann Mullally and
  • Steven W. Lane

23 August 2020

Myelofibrosis (MF) is subtype of myeloproliferative neoplasm (MPN) characterized by a relatively poor prognosis in patients. Understanding the factors that drive MF pathogenesis is crucial to identifying novel therapeutic approaches with the potentia...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Review
  • Open Access
20 Citations
10,505 Views
17 Pages

13 June 2023

The myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) category comprises a varied group of myeloid neoplastic diseases characterized by clinical and pathologic overlapping features of both myelodysplastic and myeloproliferative neoplas...

(This article belongs to the Special Issue Molecular Genetics and Treatment of Chronic Myeloid Leukemia)
  • Review
  • Open Access
40 Citations
4,695 Views
11 Pages

The Role of Inflammation and Inflammasome in Myeloproliferative Disease

  • Lucia Longhitano,
  • Giovanni Li Volti,
  • Cesarina Giallongo,
  • Mariarita Spampinato and ,
  • Ignazio Barbagallo,
  • Michelino Di Rosa,
  • Alessandra Romano,
  • Roberto Avola,
  • Daniele Tibullo and
  • Giuseppe Alberto Palumbo
  • + 5 authors+ 0 author

22 July 2020

Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are rare hematological conditions known as myeloproliferative neoplasms (MPNs). They are characterized for being BCR-ABL negative malignancies and affected patient...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
21 Citations
4,556 Views
24 Pages

Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms

  • Sophie Allain-Maillet,
  • Adrien Bosseboeuf,
  • Nicolas Mennesson,
  • Mégane Bostoën and ,
  • Laura Dufeu,
  • Eun Ho Choi,
  • Cédric Cleyrat,
  • Olivier Mansier,
  • Eric Lippert and
  • Sylvie Hermouet
  • + 10 authors+ 5 authors

28 August 2020

Inflammatory cytokines play a major role in myeloproliferative neoplasms (MPNs) as regulators of the MPN clone and as mediators of clinical symptoms and complications. Firstly, we investigated the effect of JAK2V617F on 42 molecules linked to inflamm...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Review
  • Open Access
15 Citations
5,986 Views
13 Pages

Experimental Modeling of Myeloproliferative Neoplasms

  • Lucie Lanikova,
  • Olga Babosova and
  • Josef T. Prchal

15 October 2019

Myeloproliferative neoplasms (MPN) are genetically very complex and heterogeneous diseases in which the acquisition of a somatic driver mutation triggers three main myeloid cytokine receptors, and phenotypically expresses as polycythemia vera (PV), e...

(This article belongs to the Special Issue Animal Modeling in Cancer)
  • Article
  • Open Access
2 Citations
707 Views
19 Pages

Metal-Phenolic Networks Delay the Oxidation of Alkaline High-Protein Gel Foods: Improving the Quality of Coated Tofu

  • Jian Zeng,
  • Xiaohu Zhou,
  • Yang Liu,
  • Bing Wei and ,
  • Xinrui Diao,
  • Jie Chen,
  • Saihua Sun,
  • Xiangjun Li,
  • Xuejiao Zhang and
  • Xiangle Huang
  • + 10 authors+ 5 authors

30 April 2026

Under alkaline conditions, most commonly used preservatives exhibit limited efficacy and fail to meet the preservation requirements of coated tofu. This study aims to investigate the effects of metal-phenolic networks (MPNs) on quality deterioration,...

(This article belongs to the Special Issue Gels for Plant-Based Food Applications (2nd Edition))
  • Review
  • Open Access
357 Views
18 Pages

13 October 2026

Toll-like receptor 2 (TLR2) is a versatile pattern-recognition receptor of the innate immune system that recognizes both pathogen-associated molecular patterns (PAMPs) and endogenous danger-associated molecular patterns (DAMPs). Philadelphia chromoso...

(This article belongs to the Special Issue Metabolic Dynamics and Immune Surveillance in the Tumor Microenvironment)
  • Review
  • Open Access
23 Citations
16,956 Views
17 Pages

18 January 2022

Myeloproliferative neoplasms (MPN) are a group of blood cancers in which the bone marrow (BM) produces an overabundance of erythrocyte, white blood cells, or platelets. Philadelphia chromosome-negative MPN has three subtypes, including polycythemia v...

(This article belongs to the Topic Blood Physiology: Molecular Mechanisms of Vascular Wall Functioning)
  • Review
  • Open Access
10 Citations
4,379 Views
22 Pages

Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios

  • Francesca Palandri,
  • Massimo Breccia,
  • Valerio De Stefano and
  • Francesco Passamonti

23 September 2021

An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) started in December 2019 in China and then become pandemic in February 2020. Several publications investigated the possible increased rate of COVID-19 infection in hematologic...

(This article belongs to the Special Issue Pathogenesis and Natural History of Myeloproliferative Neoplasms)
  • Article
  • Open Access
20 Citations
13,220 Views
18 Pages

Body Mass Index and Total Symptom Burden in Myeloproliferative Neoplasms Discovery of a U-shaped Association

  • Sarah Friis Christensen,
  • Robyn Marie Scherber,
  • Nana Brochmann,
  • Martin Goros and ,
  • Jonathan Gelfond,
  • Christen Lykkegaard Andersen,
  • Esben Meulengracht Flachs and
  • Ruben Mesa
  • + 3 authors+ 0 author

6 August 2020

Elevated body mass index (BMI) is a global health problem, leading to enhanced mortality and the increased risk of several cancers including essential thrombocythemia (ET), a subtype of the Philadelphia-chromosome negative myeloproliferative neoplasm...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Article
  • Open Access
987 Views
18 Pages

NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation

  • Mirjam Elisabeth Hoeness,
  • Franziska Zell,
  • Titiksha Basu,
  • Katharina Gellrich and ,
  • Albert Gründer,
  • Jana Schulze,
  • Anja Müller,
  • Philipp Eble,
  • Christoph Koellerer and
  • Hans Felix Staehle
  • + 8 authors+ 3 authors

16 December 2025

Myeloproliferative neoplasms (MPNs) are clonal hematopoietic disorders characterized by the abnormal proliferation of myeloid cells. In addition to the main driver mutations in JAK2, MPL, and CALR, the transcription factor nuclear factor erythroid 2...

(This article belongs to the Special Issue Hematological Malignancies: Molecular Mechanisms and Therapy, 2nd Edition)
  • Article
  • Open Access
12 Citations
5,504 Views
11 Pages

The detection and enumeration of Legionella pneumophila (L. pneumophila) in water is crucial for water quality management, human health and has been a research hotspot worldwide. Due to the time-consuming and complicated operation of the plate cultur...

  • Systematic Review
  • Open Access
6 Citations
4,054 Views
17 Pages

Pediatric Philadelphia-Negative Myeloproliferative Neoplasms in the Era of WHO Classification: A Systematic Review

  • Abdulrahman F. Al-Mashdali,
  • Mahmood B. Aldapt,
  • Alaa Rahhal,
  • Yousef M. Hailan and ,
  • Israa Elhakeem,
  • Elrazi A. Ali,
  • Waail Rozi and
  • Mohamed A. Yassin
  • + 3 authors+ 0 author

Background: Philadelphia-negative myeloproliferative neoplasms (MPN) are most prevalent in the older population (median age at the diagnosis is above 60 years) and rarely diagnosed in pediatrics. Thus, our knowledge about the clinical presentation, m...

(This article belongs to the Special Issue Haematology: Diagnosis and Management)
  • Review
  • Open Access
38 Citations
8,922 Views
25 Pages

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies

  • Vincenzo Nasillo,
  • Giovanni Riva,
  • Ambra Paolini,
  • Fabio Forghieri and ,
  • Luca Roncati,
  • Beatrice Lusenti,
  • Monica Maccaferri,
  • Andrea Messerotti,
  • Valeria Pioli and
  • Tommaso Trenti
  • + 18 authors+ 13 authors

14 February 2021

The Philadelphia-negative myeloproliferative neoplasms (MPNs) are malignancies of the hematopoietic stem cell (HSC) arising as a consequence of clonal proliferation driven by somatically acquired driver mutations in discrete genes (JAK2, CALR, MPL)....

(This article belongs to the Special Issue BCR-ABL1 Negative Myeloproliferative Neoplasms)
  • Feature Paper
  • Review
  • Open Access
24 Citations
7,016 Views
33 Pages

Immunotherapy in Myeloproliferative Diseases

  • Lukas M. Braun and
  • Robert Zeiser

26 June 2020

Myeloproliferative diseases, including myeloproliferative neoplasms (MPN) and myelodysplastic syndromes (MDS), are driven by genetic abnormalities and increased inflammatory signaling and are at high risk to transform into acute myeloid leukemia (AML...

(This article belongs to the Special Issue Pathophysiology and Molecular Targets in Myeloid Neoplasia)
  • Communication
  • Open Access
1,211 Views
8 Pages

Frequency of Non-Type I/II CALR Mutations in Patients Undergoing Molecular Diagnostics for Myeloproliferative Neoplasms

  • Tatiana Makarik,
  • Elena Nikulina,
  • Svetlana Treglasova,
  • Elena Stepanova and ,
  • Natalia Chernova,
  • Bella Biderman,
  • Alina Kokhno and
  • Andrey Sudarikov
  • + 3 authors+ 0 author

Background/Objectives: Somatic CALR gene insertions/deletions in exon 9, causing frameshift, are a diagnostic sign of myeloproliferative neoplasms (MPNs). Besides the most common somatic mutations of type I (52 bp deletion) and type II (5 bp insertio...

(This article belongs to the Special Issue Advances in Molecular Pathogenesis, Precision Medicine, and Artificial Intelligence in Hematologic Malignancies)
  • Article
  • Open Access
1 Citations
1,604 Views
13 Pages

Immunogenicity Evaluation of Six Key Antigens of Mycoplasma pneumoniae in BALB/c Mice

  • Luxia Huang,
  • Heng Zhang,
  • Hongjian Xiao,
  • Zhihua Li and
  • Qianqian Li

28 January 2026

Background/Objective: Mycoplasma pneumoniae (MP) remains a significant pathogen causing respiratory tract inflammation, particularly in the elderly and children under 5 years old. The lack of an effective vaccine is primarily attributed to the a...

  • Review
  • Open Access
9 Citations
5,002 Views
23 Pages

NK Cells in Myeloproliferative Neoplasms (MPN)

  • Erin Naismith,
  • Janine Steichen,
  • Sieghart Sopper and
  • Dominik Wolf

31 August 2021

Myeloproliferative neoplasms (MPNs) comprise a heterogenous group of hematologic neoplasms which are divided into Philadelphia positive (Ph+), and Philadelphia negative (Ph−) or classical MPNs. A variety of immunological factors including inflammator...

(This article belongs to the Special Issue Natural Killer Cells in Cancers)
  • Review
  • Open Access
29 Citations
15,303 Views
39 Pages

12 August 2014

Met is the receptor of hepatocyte growth factor (HGF), a cytoprotective cytokine. Disturbing the equilibrium between Met and its ligand may lead to inappropriate cell survival, accumulation of genetic abnormalities and eventually, malignancy. Abnorma...

(This article belongs to the Special Issue MET in Cancer)
  • Perspective
  • Open Access
6 Citations
5,649 Views
19 Pages

Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives

  • Hans Hasselbalch,
  • Vibe Skov,
  • Lasse Kjær,
  • Morten Kranker Larsen and ,
  • Trine A. Knudsen,
  • Marko Lucijanić and
  • Rajko Kusec
  • + 2 authors+ 0 author

9 November 2022

About 30 years ago, the first clinical trials of the safety and efficacy of recombinant interferon-α2 (rIFN-α2) were performed. Since then, several single-arm studies have shown rIFN-α2 to be a highly potent anticancer agent against...

(This article belongs to the Topic Advances in Anti-Cancer Drugs)
  • Article
  • Open Access
744 Views
18 Pages

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms

  • Caroline Norup Bistrup,
  • Morten Kranker Larsen,
  • Peter Junker,
  • Vibe Skov and ,
  • Lasse Kjær,
  • Trine Alma Knudsen,
  • Morten Karsdal,
  • Nicholas Willumsen and
  • Hans Carl Hasselbalch
  • + 4 authors+ 0 author

6 August 2026

Background and objectives: Myeloproliferative neoplasms (MPNs) are blood cancers characterized by elevated blood cell counts, bone marrow fibrosis (BMF), and chronic inflammation, which drives disease progression. BMF results from disrupted collagen...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
3 Citations
2,382 Views
17 Pages

This study describes the seasonal course of denitrifying and nitrate-reducing bacteria in a dimictic mesotrophic lake (Lake Scharmützelsee, Brandenburg, Germany) within a three-year period from 2011 to 2013. The bacterial cell numbers were quant...

(This article belongs to the Section Environmental Microbiology)
  • Review
  • Open Access
5,082 Views
12 Pages

14 December 2021

Philadelphia chromosome negative myeloproliferative neoplasms (MPN) are clonal haematopoietic stem cell disorders. Of the MPNs, polycythaemia vera (PV) and essential thrombocythaemia (ET) confer a high thrombotic risk which may be the presenting feat...

(This article belongs to the Section Chronic Myeloid Disease)
  • Review
  • Open Access
1 Citations
4,225 Views
21 Pages

Myelodysplastic/Myeloproliferative Neoplasms with Features Intermediate between Primary Myelofibrosis and Chronic Myelomonocytic Leukemia: Case Series and Review of the Entity

  • Arturo Bonometti,
  • Simone Zanella,
  • Daoud Rahal,
  • Chiara Milanesi and ,
  • Rossella Caselli,
  • Matteo Giovanni Della Porta,
  • Silvia Uccella and
  • Sara Fraticelli
  • + 3 authors+ 0 author

7 July 2024

Diagnosis of myeloid neoplasm is currently performed according to the presence of a predetermined set of clinical, morphological, and molecular diagnostic criteria agreed upon by a consensus of experts. Even strictly adhering to these criteria, it is...

(This article belongs to the Section Chronic Myeloid Disease)
  • Review
  • Open Access
17 Citations
8,724 Views
15 Pages

Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN

  • Gajalakshmi Ramanathan,
  • Brianna M Hoover and
  • Angela G Fleischman

24 July 2020

Philadelphia-negative myeloproliferative neoplasms (MPNs) occur when there is over-production of myeloid cells stemming from hematopoietic stem cells with constitutive activation of JAK/STAT signaling, with JAK2V617F being the most commonly occurring...

(This article belongs to the Special Issue New Insights into Myeloproliferative Neoplasms)
  • Review
  • Open Access
12 Citations
8,950 Views
34 Pages

Current Advances in the Diagnosis and Treatment of Major Myeloproliferative Neoplasms

  • Le Wang,
  • Julie Li,
  • Leah Arbitman,
  • Hailing Zhang and ,
  • Haipeng Shao,
  • Michael Martin,
  • Lynn Moscinski and
  • Jinming Song
  • + 3 authors+ 0 author

30 May 2025

Myeloproliferative neoplasms (MPNs) are a group of rare blood cancers characterized by the excessive production of blood cells in the bone marrow. These disorders arise from acquired genetic driver mutations, with or without underlying genetic predis...

(This article belongs to the Special Issue Molecular and Genetic Diagnosis and Targeted Therapy of Myeloproliferative Neoplasms)
  • Review
  • Open Access
16 Citations
9,157 Views
16 Pages

Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape

  • Muftah Mahmud,
  • Swati Vasireddy,
  • Krisstina Gowin and
  • Akshay Amaraneni

12 December 2023

Myelofibrosis (MF), Myeloproliferative neoplasms (MPNs), and MDS/MPN overlap syndromes have a broad range of clinical presentations and molecular abnormalities, making their diagnosis and classification complex. This paper reviews molecular aberratio...

(This article belongs to the Special Issue Molecular Research on Myeloproliferative Disorders)

of 11